Skip to main content
logo
Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
156.82
-0.08 (-0.05%)
At close: Jul 14, 2025, 4:00 PM
156.80
-0.02 (-0.01%)
After-hours: Jul 14, 2025, 4:14 PM EDT

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $21.89B in the quarter ending March 30, 2025, with 2.39% growth. This brings the company's revenue in the last twelve months to $89.33B, up 4.30% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.

Revenue (ttm)
$89.33B
Revenue Growth
+4.30%
P/S Ratio
4.23
Revenue / Employee
$646,857
Employees
138,100
Market Cap
377.32B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 29, 2024 88.82B 3.66B 4.30%
Dec 31, 2023 85.16B 5.17B 6.46%
Jan 1, 2023 79.99B 1.25B 1.59%
Jan 2, 2022 78.74B -3.84B -4.65%
Jan 3, 2021 82.58B 525.00M 0.64%
Dec 29, 2019 Pro Pro Pro
Dec 30, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Jan 1, 2017 Pro Pro Pro
Jan 3, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Thermo Fisher Scientific 42.90B
Revenue Rankings

JNJ News

More News